This inventor holds 2 USPTO granted patents. Top assignees: Adjutec Pharma as, Other. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Ørjan Samuelson: Innovator in Pharmaceutical Chemistry
Introduction
Ørjan Samuelson is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating cancer and bacterial diseases. With a total of 2 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
Samuelson's latest patents include innovative methods and compositions aimed at combating serious health issues. One of his patents focuses on substituted phenazines and methods of treating cancer and bacterial diseases. This patent describes a combination product that includes a carbapenem and a specific compound, along with a pharmaceutical composition that utilizes this combination for treating bacterial or fungal infections. Another patent also centers on substituted phenazines, detailing compounds and pharmaceutical compositions that offer methods of treatment for various diseases.
Career Highlights
Throughout his career, Ørjan Samuelson has worked with Adjutec Pharma AS, where he has contributed to the advancement of pharmaceutical products. His expertise in the field has allowed him to develop innovative solutions that address critical health challenges.
Collaborations
Samuelson has collaborated with notable professionals in his field, including Pål Rongved and Ove Alexander Høgmoen Åstrand. These collaborations have further enriched his research and development efforts.
Conclusion
Ørjan Samuelson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile